The FDA wants to end bulk production of copycat versions of weight loss drugs; telehealth companies and compounding ...

GLP-1 agonists remain out of reach for many due to high costs, leading some patients to turn to unsafe compounded versions ...

A Review of the Research Progress and Application of Skin Care Ointments in Chronic Eczema Treatment ...

Compounding pharmacies have been allowed to essentially make a cheaper version of Eli Lilly's Zepbound, but they have to stop ...

The versions affected are called compounded medications, which have the same active ingredients as the name brands. The ...

Large-scale compounding facilities have to stop making tirzepatide, the main ingredient in blockbuster obesity drug Zepbound, Wednesday.

Compounding pharmacy FarmaKeio NM is cementing its role as a crucial part of Winrock Town Center's developing wellness sector. The pharmacy, formerly City Drug, rebranded and relocated to 2100 ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight ...

A group of compounding pharmacies has filed a lawsuit against the FDA, challenging the agency’s decision to remove semaglutide — which is used to treat Type 2 diabetes and obesity — from the ...

Many major organizations have publicly opposed the Board’s proposal and are major players in the opposition efforts, including the Alliance for Pharmacy Compounding, Volunteer Fire Foundation ...